Lactose Market to Grow at 10.0% CAGR over 2023 to 2030; MEGGLE Wasserburg GmbH Lauched InhaLac 300 at PBP 2021 to Strengthen Industry Foothold

The global lactose market size stood at USD 2.72 billion in 2022. The market value is slated to rise from USD 1.72 billion in 2023 to USD 3.36 billion by 2030 at a CAGR of 10.0% during 2023-2030.

Fortune Business Insights™ presents this information in its report titled “Lactose Market Size, Share & COVID-19 Impact Analysis, By Application (Food, Feed, Pharmaceuticals, and Infant Formula {Dry-blend, and Wet-blend}), By Color (Yellow, Pale-Yellow to White, and White), By Purity (Crude, Edible, and Refined Edible), and Regional Forecast, 2023-2030”.

Lactose is extensively used in filler/excipient and infant formula manufacturing in the pharmaceutical industry. The product is used in the food sector for producing bakery products, creams, and confectioneries. The industry expansion is being driven by the soaring product demand from developing countries. Additional factor impelling the industry growth is the rising demand for infant-grade solutions from key dairy-producing nations.

COVID-19 Pandemic Led to Spike in Product Prices Favoring Industry Expansion

The pandemic did not affect production facilities given that dairy foods were categorized as essential items during the period. However, stable production and reduced supply ramped up product prices, positively influencing industry expansion. According to GlobalDairyTrade, the product’s annual weighted average price surged to USD 1,224 per MT in 2021 from USD 1,093 MT in 2020.

Lactalis Ingredients Debuted the Pharma Sector to Strengthen Market Footing

In October 2023, Lactalis Ingredients entered the pharmaceutical industry. Through the debut, the organization would serve pharmaceutical manufacturers and companies across the globe. The company has launched its sieved and milled lactose monohydrate range Lactalpha. The company has an extensive range of white and standard lactose for clinical, infant, and food applications. According to the company, lactose is a vital excipient used in the formulation of oral solid dosage forms such as sachets, capsules, and tablets.

Product Demand to Surge with Decline in Global Rates of Breastfeeding

There has been a drop in the global rates of breastfeeding considering the availability of breast milk substitutes and an upsurge in the working population. This has led to a greater emphasis on the development of infant formula, which is boosting the demand for infant-grade products at the global level. These factors are expected to drive lactose market growth.  

However, the industry expansion could be affected due to the rising population with lactose intolerance.

Industry Players Undertake R&D Initiatives to Introduce New Products

Market players are depicting a greater inclination toward the adoption of research and development activities. Through these initiatives, companies intend to bring advanced products to the market. These steps are being implemented to sustain the market competition. A few of the leading industry players include Sachsenmilch Leppersdorf GmbH and MEGGLE GmbH & Co. KG.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/lactose-market-101774

List of Key Players Profiled:

• Fonterra Co-operative Group (New Zealand)


• FrieslandCampina (Netherlands)


• DFE Pharma (Germany)


• MILEI GmbH (MORINAGA MILK INDUSTRY CO., LTD.) (Germany)


• Arla Foods Ingredients Group P/S (Denmark)


• MEGGLE GmbH & Co. KG (Denmark)


• Lactose (India) Limited (India)


• Hilmar Cheese Company, Inc. (U.S.)


• Kerry Group plc. (Ireland)


• Käserei Champignon Hofmeister GmbH & Co. KG (ALPAVIT) (Germany)


• Armor Proteines (SAVENCIA SA) (France)


• Glanbia PLC (Ireland)


• Lactalis International (Lactalis Group) (France)


• Milk Specialties Global (U.S.)   

Key Industry Development

• In May 2021, MEGGLE Wasserburg GmbH shared plans to exhibit InhaLac 300 at the 12^th Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology conference, PBP World Meeting 2021, which was held online. The product was unveiled as the latest addition to the company’s advanced pharmaceutical lactose excipient range. 

Further Report Findings:

• Asia Pacific market accounted for a major market share in 2022. The regional market size hit a valuation of USD 1.60 billion in 2022. The regional expansion can be credited to an upsurge in strategic expansion plans by leading players.


• Europe held the second-largest lactose market share. The presence of a well-established dairy sector is poised to augur well for the market, boosting industry expansion.


• The Middle East & Africa and South America regions exhibit a robust demand for infant formula. This factor is expected to drive the market growth in these regions.


• On the basis of purity, the market is segregated into refined-edible grade, edible grade, and crude grade. The refined-edible grade segment registered a major market share in 2022. The segment’s growth can be attributed to the strict specification requirement, which has priced this grade higher than other grades.


• By application, the market is fragmented into infant formula, pharmaceuticals, feed, and food. Of these, the infant formula segment is poised to hold a prominent market share over the study period. The segmental expansion is driven by the surging emphasis on the domestic production of infant formula in China.  

Table of Segmentation